Old Web
English
Sign In
Acemap
>
Paper
>
P1.14-50 A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma
P1.14-50 A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma
2019
Robin Guo
Isabel Ruth Preeshagul
Adam J. Schoenfeld
C. McCarthy
Alex Makhnin
Andrew J. Plodkowski
Michelle S. Ginsberg
Monika A. Davare
Lukas Delasos
Romel Somwar
Maria E. Arcila
G. J. Riely
Natasha Rekhtman
M. Ladanyi
Mark G. Kris
A. Drilon
Keywords:
Pathology
Oncology
Adenocarcinoma
ROS1
Lung
Cabozantinib
Medicine
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]